Vytrus Biotech, S.A.'s latest marketcap:
As of 07/28/2025, Vytrus Biotech, S.A.'s market capitalization has reached $27.63 M. According to our data, Vytrus Biotech, S.A. is the 34291th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 27.63 M |
| Revenue (ttm) | 7.1 M |
| Net Income (ttm) | 1.19 M |
| Shares Out | 7.54 M |
| EPS (ttm) | 0.16 |
| Forward PE | 23.01 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
Vytrus Biotech, S.A.'s yearly market capitalization.
| Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/28/2025 | €24.58 M | $27.63 M | 163.31% | 34291 |
| 12/31/2024 | €16.29 M | $16.86 M | 29.02% | 35247 |
| 12/29/2023 | €12.62 M | $13.93 M | -46.26% | 35599 |
| 12/30/2022 | €23.49 M | $25.14 M | 31346 |
Company Profile
Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells for the cosmetic sector primarily in Spain.
It offers Nectaria Lithops, an active ingredient that biophysically optimizes the skin microenvironment and vitamin D levels; Photobiome a microbiota photoprotector; Olea Vitae cellular oil for ageing; Turmeria Zen for skin hydration and wrinkles on stressed profiles; Sensia Carota, a plant-based active that protects and prevents from the damage on sensitive and sensitized skins; Deobiome Noni, a biological deodorant; and Sarcoslim Re-Shape to reduce fat on tissue.
The company also offers Capilia Longa for hair growth reactivation; Luminia Granatum for skin brightening;Elaya Renova a hair tensegrist; Kannabia Sense that stimulates the microbiota-skin-brain axis; Quora Noni to avoid the attack of skin harmful bacteria; Quora Noni biomics for rejuvenating the skin microbiota; Centella Reversa for facial complexion improvement; and Arabian Cotton for protection against photo-ageing.
It sells its products to approximately 560 countries. Vytrus Biotech, S.A. was incorporated in 2009 and is based in Barcelona, Spain.
Frequently Asked Questions
-
What is Vytrus Biotech, S.A.'s (BME-VYT) current market cap?As of 07/28/2025, Vytrus Biotech, S.A. (including the parent company, if applicable) has an estimated market capitalization of $27.63 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Vytrus Biotech, S.A. (BME-VYT) rank globally by market cap?Vytrus Biotech, S.A. global market capitalization ranking is approximately 34291 as of 07/28/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.